Literature DB >> 10461843

Vaginal disinfection with chlorhexidine during childbirth.

B Stray-Pedersen1, T Bergan, A Hafstad, E Normann, J Grøgaard, M Vangdal.   

Abstract

The purpose of this study was to determine whether chlorhexidine vaginal douching, applied by a squeeze bottle intra partum, reduced mother-to-child transmission of vaginal microorganisms including Streptococcus agalactiae (streptococcus serogroup B = GBS) and hence infectious morbidity in both mother and child. A prospective controlled study was conducted on pairs of mothers and their offspring. During the first 4 months (reference phase), the vaginal flora of women in labour was recorded and the newborns monitored. During the next 5 months (intervention phase), a trial of randomized, blinded placebo controlled douching with either 0.2% chlorhexidine or sterile saline was performed on 1130 women in vaginal labour. During childbirth, bacteria were isolated from 78% of the women. Vertical transmission of microbes occurred in 43% of the reference deliveries. In the double blind study, vaginal douching with chlorhexidine significantly reduced the vertical transmission rate from 35% (saline) to 18% (chlorhexidine), (P < 0.000 1, 95% confidence interval 0.12-0.22). The lower rate of bacteria isolated from the latter group was accompanied by a significantly reduced early infectious morbidity in the neonates (P < 0.05, 95% confidence interval 0.00-0.06). This finding was particularly pronounced in Str. agalactiae infections (P < 0.0 1). In the early postpartum period, fever in the mothers was significantly lower in the patients offered vaginal disinfection, a reduction from 7.2% in those douched using saline compared with 3.3% in those disinfected using chlorhexidine (P < 0.05, 95% confidence interval 0.01-0.06). A parallel lower occurrence of urinary tract infections was also observed, 6.2% in the saline group as compared with 3.4% in the chlorhexidine group (P < 0.01, 95% confidence p interval 0.00-0.05). This prospective controlled trial demonstrated that vaginal douching with 0.2% chlorhexidine during labour can significantly reduce both maternal and early neonatal infectious morbidity. The squeeze bottle procedure was simple, quick, and well tolerated. The beneficial effect may be ascribed both to mechanical cleansing by liquid flow and to the disinfective action of chlorhexidine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461843     DOI: 10.1016/s0924-8579(99)00068-0

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  9 in total

Review 1.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

Review 2.  Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries.

Authors:  Luke C Mullany; Gary L Darmstadt; James M Tielsch
Journal:  Pediatr Infect Dis J       Date:  2006-08       Impact factor: 2.129

3.  Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1.

Authors:  Shendra R Passic; Mary Lee Ferguson; Bradley J Catalone; Tina Kish-Catalone; Vladyslav Kholodovych; Wei Zhu; William Welsh; Robert Rando; Mary K Howett; Brian Wigdahl; Mohamed Labib; Fred C Krebs
Journal:  Biomed Pharmacother       Date:  2010-11-04       Impact factor: 6.529

4.  Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.

Authors:  Nina Thakkar; Vanessa Pirrone; Shendra Passic; Wei Zhu; Vladyslav Kholodovych; William Welsh; Robert F Rando; Mohamed E Labib; Brian Wigdahl; Fred C Krebs
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

Review 5.  The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings.

Authors:  E M McClure; R L Goldenberg; N Brandes; G L Darmstadt; L L Wright; Deborah Armbruster; Robert Biggar; Joyce Carpenter; Michael J Free; Donald Mattison; Matthews Mathai; Nancy Moss; Luke C Mullany; Stephanie Schrag; James Tielsch; Jorge Tolosa; Stephen N Wall; Anne Schuchat; Abdelkrim Smine
Journal:  Int J Gynaecol Obstet       Date:  2007-03-30       Impact factor: 3.561

Review 6.  Vaginal chlorhexidine during labour for preventing maternal and neonatal infections (excluding Group B Streptococcal and HIV).

Authors:  Pisake Lumbiganon; Jadsada Thinkhamrop; Bandit Thinkhamrop; Jorge E Tolosa
Journal:  Cochrane Database Syst Rev       Date:  2014-09-14

7.  Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model.

Authors:  Karissa Lozenski; Tina Kish-Catalone; Vanessa Pirrone; Robert F Rando; Mohamed Labib; Brian Wigdahl; Fred C Krebs
Journal:  J Biomed Biotechnol       Date:  2011-10-24

8.  A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment.

Authors:  Eldin Jašarević; Ali B Rodgers; Tracy L Bale
Journal:  Neurobiol Stress       Date:  2015-01-01

9.  What is the result of vaginal cleansing with chlorhexidine during labour on maternal and neonatal infections? A systematic review of randomised trials with meta-analysis.

Authors:  Charlotte Bell; Laura Hughes; Trevor Akister; Vin Ramkhelawon; Amie Wilson; David Lissauer
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-08       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.